|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
49,450,000 |
Market
Cap: |
1.51(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$25.5 - $41.52 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 623 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and ioveradeg®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
119,323 |
119,323 |
189,781 |
290,198 |
Total Sell Value |
$3,656,226 |
$3,656,226 |
$6,334,261 |
$12,063,571 |
Total People Sold |
1 |
1 |
15 |
16 |
Total Sell Transactions |
3 |
3 |
34 |
58 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Riker Lauren Bullaro |
Vice President, Finance |
|
2020-02-06 |
4 |
OE |
$10.81 |
$8,972 |
D/D |
830 |
11,294 |
|
- |
|
Stack David M |
CEO and Chairman |
|
2020-01-15 |
4 |
AS |
$42.61 |
$1,066,968 |
I/I |
(25,000) |
1,208 |
|
5% |
|
Stack David M |
CEO and Chairman |
|
2020-01-15 |
4 |
OE |
$10.81 |
$270,250 |
I/I |
25,000 |
26,208 |
|
- |
|
Stack David M |
CEO and Chairman |
|
2019-12-26 |
4 |
OE |
$1.61 |
$71,000 |
D/D |
20,000 |
162,299 |
|
- |
|
Riker Lauren Bullaro |
Vice President, Finance |
|
2019-12-23 |
4 |
AS |
$45.92 |
$45,920 |
D/D |
(1,000) |
10,464 |
|
- |
|
Riker Lauren Bullaro |
Vice President, Finance |
|
2019-12-23 |
4 |
OE |
$10.81 |
$10,810 |
D/D |
1,000 |
11,464 |
|
- |
|
Froimson Mark |
Director |
|
2019-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
300 |
4,716 |
|
- |
|
Mcloughlin Dennis |
Chief Commercial Officer |
|
2019-12-16 |
4 |
S |
$45.79 |
$168,108 |
D/D |
(3,671) |
16,116 |
|
- |
|
Longenecker John P Phd |
Director |
|
2019-12-02 |
4 |
S |
$46.13 |
$59,972 |
D/D |
(1,300) |
12,761 |
|
- |
|
Longenecker John P Phd |
Director |
|
2019-12-02 |
4 |
OE |
$1.61 |
$6,440 |
D/D |
4,000 |
14,061 |
|
- |
|
Riker Lauren Bullaro |
Vice President, Finance |
|
2019-11-20 |
4 |
S |
$44.14 |
$51,909 |
D/D |
(1,176) |
10,464 |
|
- |
|
Riker Lauren Bullaro |
Vice President, Finance |
|
2019-11-20 |
4 |
OE |
$10.81 |
$10,810 |
D/D |
1,000 |
11,640 |
|
- |
|
Stack David M |
CEO and Chairman |
|
2019-11-15 |
4 |
AS |
$42.81 |
$1,070,250 |
I/I |
(25,000) |
1,208 |
|
- |
|
Stack David M |
CEO and Chairman |
|
2019-11-15 |
4 |
OE |
$10.81 |
$270,250 |
I/I |
25,000 |
26,208 |
|
- |
|
Stack David M |
CEO and Chairman |
|
2019-11-15 |
4 |
AS |
$42.81 |
$1,926,450 |
D/D |
(45,000) |
142,299 |
|
- |
|
Riker Lauren Bullaro |
Vice President, Finance |
|
2019-11-11 |
4 |
S |
$43.59 |
$217,950 |
D/D |
(5,000) |
10,640 |
|
- |
|
Riker Lauren Bullaro |
Vice President, Finance |
|
2019-11-11 |
4 |
OE |
$10.34 |
$51,785 |
D/D |
5,000 |
15,640 |
|
- |
|
Scranton Richard |
Chief Scientific Officer |
|
2019-11-08 |
4 |
AS |
$45.00 |
$875,160 |
D/D |
(19,448) |
16,061 |
|
- |
|
Scranton Richard |
Chief Scientific Officer |
|
2019-11-08 |
4 |
OE |
$10.81 |
$279,393 |
D/D |
19,448 |
35,509 |
|
- |
|
Stack David M |
CEO and Chairman |
|
2019-10-02 |
4 |
OE |
$1.61 |
$66,170 |
D/D |
17,000 |
187,299 |
|
- |
|
Stack David M |
CEO and Chairman |
|
2019-09-18 |
4 |
OE |
$1.61 |
$47,760 |
D/D |
14,000 |
170,299 |
|
- |
|
Stack David M |
CEO and Chairman |
|
2019-08-15 |
4 |
AS |
$39.05 |
$503,092 |
D/D |
(12,849) |
156,299 |
|
- |
|
Stack David M |
CEO and Chairman |
|
2019-08-15 |
4 |
OE |
$10.81 |
$138,898 |
D/D |
12,849 |
169,148 |
|
- |
|
Dunker Kristen Marie |
Chief Administrative Officer |
|
2019-08-14 |
4 |
AS |
$39.49 |
$246,891 |
D/D |
(6,252) |
19,193 |
|
- |
|
Stack David M |
CEO and Chairman |
|
2019-07-08 |
4 |
AS |
$42.85 |
$562,377 |
D/D |
(13,115) |
156,299 |
|
- |
|
781 Records found
|
|
Page 13 of 32 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|